Not Yet Recruiting A Phase I/II, First-In-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Activity to Prevent or Treat Neuropsychiatric Symptoms in Pediatric Subjects With Timothy Syndrome NCT07600658 Conditions CACNA1C, Timothy syndrome Locations Stanford University — Stanford, California, United States View Trial Details
Completed Baby Detect : Genomic Newborn Screening NCT05687474 Conditions 3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more Locations CRMN, Hôpital La Citadelle — Liège, Wallonia, Belgium View Trial Details
